Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Netherlands
MedTech
Meet Aletta: The 1st FDA approved robotic blood draw device
The FDA has approved Aletta as the first standalone robotic device in the U.S. designed to draw blood without the need for hands-on human help.
Ben Adams
Aug 20, 2026 9:47am
Synaffix allies with Emergence in $360M biobuck ADC pact
Sep 6, 2022 8:50am
Netherlands makes $350M bet on preclinical cancer development
Apr 15, 2022 7:50am
RNA sequencing enhances pediatric cancer diagnoses: study
Jan 28, 2022 2:13pm
Lumicks snags $93M for its molecular tweezers, CAR-T hardware
Apr 19, 2021 9:45am
MercachemSyncom snaps up Admescope to boost early-stage R&D work
Nov 11, 2020 7:39am
